February 01, 2019 Share this content: Improving adherence with high-intensity lipid lowering therapies could greatly reduce CVD risk. Patients with cardiovascular disease or cardiovascular risk factors who adhere with high-intensity statin and/or ezetimibe therapy have a lower risk for cardiovascular events vs patients who do not adhere with low-intensity therapy. This is according to findings from a retrospective cohort study …